Effects of recombinant human erythropoietin on serum levels of neuron-specific enolase, S-100β protein and myelin basic protein in rats following status epilepticus

Chinese Journal of Contemporary Pediatrics

Volumn 13, Issue 1, 2011, Pages 50-52

  Jiang, Chun Ming ^a   Du, Jian Min ^a   Liu, Zhan Li ^a   Chen, Li Qiong ^a   Feng, Mei ^a   Yang, Yi Hua ^a   Wang, Jie Hua ^a   Huang, Xian Mei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Erythropoietin; Neuron specific enolase; Rats; S 100 protein; Status epilepticus

Indexed keywords

LITHIUM; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; PILOCARPINE; PROTEIN S100B; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DAMAGE; BRAIN INJURY; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; EPILEPTIC STATE; HUMAN; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ERYTHROPOIETIN, RECOMBINANT; MALE; MYELIN BASIC PROTEINS; NERVE GROWTH FACTORS; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; S100 PROTEINS; STATUS EPILEPTICUS;

EID: 79851502473     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kondralyev A, Gale K. Temporal and spatial patterns of DNA fragmentation following focally or systemically-evoked status epilepticus in rats[J]. Neurosci Lett, 2001, 310(1): 13-16. (Pubitemid 32778473)
2. Covolan L, Smith RL, Mello LE. Ultrastructural identification of dentate granule cell death from pilocarpine-induced seizures[J]. Epilepsy Res, 2000, 41(1): 9-21. (Pubitemid 30621397)
3. Buemi M, Donate V, Bolignano D. Erythropoientin: pleiotropic actions[J]. Recenti Prog Med, 2010, 101(6): 253-267.
4. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes[J]. J Biol Chem, 1994, 269 (30): 19488-19493.
5. Li Y, Lu Z, Keogh CL, Yu SP, Wei L. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice[J]. J Cereb Blood Flow Metab, 2007, 27(5): 1043-1054. (Pubitemid 46659037)
6. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure[J]. Electroencephalogr Clin Neurophysiol, 1972, 32(3): 281-294.
7. Chu K, Jung KH, Lee ST, Kim JH, Kang KM, Kim HK, et al. Erythropoietin reduces epileptogenic processes following status epilepticus[J]. Epilepsia, 2008, 49(10): 1723-1732.
8. Li Y, Lu ZY, Ogle M, Wei L. Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice[J]. Neurochem Res, 2007, 32(12): 2132-2141. (Pubitemid 350059857)
9. Keller M, Yang J, Griesmaier E, Gorna A, Sarkozy G, Urbanek M, et al. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice[J]. Neurobiol Dis, 2006, 24(2): 357-366.
10. Kondo A, Shingo T, Yasuhara T, Kuramoto S, Kameda M, Kikuchi Y, et al. Erythropoietin exerts anti-epileptic effects with the suppression of aberrant new cell formation in the dentate gyrus and upregulation of neuropeptide Y in seizure model of rats[J]. Brain Res, 2009, 3(1296): 127-136.
11. Jun Y, JiangTao X, YuanGui H, YongBin S, Jun Z, Xiaojun M, et al. Erythropoietin pre-treatment prevents cognitive impairments following status epilepticus in rats[J]. Brain Res, 2009, 1282: 57-66.